SMSPHARMA (India) Performance

SMSPHABBPH -- India Stock  

INR 235.70  0.00  0.00%

The entity has beta of 0.0 which indicates the returns on MARKET and SMSPHARMA are completely uncorrelated. Although it is extremely important to respect SMSPHARMA current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By evaluating SMSPHARMA technical indicators you can currently evaluate if the expected return of 0.0% will be sustainable into the future. SMSPHARMA presently has a risk of 0.0%. Please validate SMSPHARMA Jensen Alpha and Downside Variance to decide if SMSPHARMA will be following its existing price patterns.

Risk-Adjusted Performance

Over the last 30 days SMSPHARMA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, SMSPHARMA is not utilizing all of its potentials. The new stock price disturbance, may contribute to short term losses for the investors.
Horizon     30 Days    Login   to change

SMSPHARMA Relative Risk vs. Return Landscape

If you would invest  23,570  in SMSPHARMA on May 26, 2019 and sell it today you would earn a total of  0.00  from holding SMSPHARMA or generate 0.0% return on investment over 30 days. SMSPHARMA is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than SMSPHARMA and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 

SMSPHARMA Market Risk Analysis

Sharpe Ratio = 0.0
Good Returns
Average Returns
Small Returns
Based on monthly moving average SMSPHARMA is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SMSPHARMA by adding it to a well-diversified portfolio.


Equity Alerts and Improvement Suggestions

SMSPHARMA is not yet fully synchronised with the market data
Also please take a look at World Market Map. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.